PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer-Reference-Cited by-同舟云学术

PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer

Published:2017-04-11 Issue:35 Volume:8 Page:58457-58468
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Cuiling¹,Tang Jianjun²,Sun Huanhuan¹,Zheng Xiaobin³,Li Zhanyu⁴,Sun Tiantian⁵,Li Jie⁶,Wang Shuncong¹,Zhou Xiuling¹,Sun Hongliu⁷,Cheng Zhibin¹,Zhang Hongyu¹,Ma Haiqing¹

Affiliation:

1. Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China

2. Department of Gastroenterology, Cancer Hospital of Jiangxi Province, Nanchang, Jiangxi 330029, China

3. Department of Respiration, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China

4. Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China

5. Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China

6. Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China

7. Department of Pathology, University of Michigan, Ann Arbor, MI 48201, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning identifies prognostic subtypes of the tumor microenvironment of NSCLC;Scientific Reports;2024-07-01

2. NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy;Frontiers in Immunology;2024-02-07

3. PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer;Lung;2022-12-30

4. PD-L1 expression is not a predictive factor for recurrence in resected non-small cell lung cancer Sub-heading: PD-L1 is not a predictive factor for recurrence;2022-10-11

5. Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer;Clinical Medicine Insights: Oncology;2022-01